Orionis Biosciences Stock

orionisbio.com/HealthcareFounded: 2015

Orionis Biosciences is a drug research, discovery, and development company with a focus on treatments for diseases that have an unmet medical need. Orionis Biosciences internal focus is in oncology and immunotherapies, operated by a team of entrepreneurs, scientists, and a transatlantic network of investors who collaborate on effective therapeutics. Orionis Biosciences is headquartered in Waltham, MA.

Register for Details

For more details on financing and valuation for Orionis Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Orionis Biosciences.

Register Today

Orionis Biosciences investors also invested in these private companies

Team

Management Team

Nikolai Kley, Ph.D.
President and Chief Executive Officer
Riccardo Sabatini, Ph. D.
Chief Data Scientist
Jan Tavernier, Ph.D.
Chief Technology Officer

Board Members

Griet Vanpoucke, Ph.D.
VIB
Matias de Tezanos
Independent Advisor
Steve Gullans, Ph.D.
Independent Advisor

Other companies like Orionis Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM

News

Orionis Biosciences, a Waltham, MA- and Gent, Belgium-based life sciences company, raised $55M in funding.